Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus ropivacaine brachial plexus block for shoulder arthroscopy
ChiCTR1800018414Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and ropivacaine in Shoulder disorder (3 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: Amount of anesthesia used during operation, Time for spontaneous breathing recovery and 7 more. Started Sep 2018; status: recruiting.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
Shoulder disorder
Beyond the preview
Go deeper on ChiCTR1800018414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018414.